Advertisement

Nanobotany pp 131-159 | Cite as

Nanobotany and Pharmaceuticals

  • Zunera Iqbal
  • Sumera Iqbal
Chapter

Abstract

Bionanotechnology is the combination of biotechnology and nanotechnology and it emerged as an ecofriendly technology for the nanomaterials’ biological synthesis. A physicist Professor Richard Feynman in his remarkable speech said “there’s plenty of room at the bottom” devised the idea of nanotechnology (1), yet the Professor Norio Taniguchi of Tokyo Science University introduced the term nanotechnology (2). Nanoparticles are regarded as groups of elements in the range of 1–100 nm. These nanoparticles possess different kind of physiochemical properties; depending upon the material and method from which they are synthesized. Nanoparticles synthesized from plants and their extracts can be safely used for pharmacological devices. This chapter covers some of the aspects in this regard.

References

  1. Ahmed S, Ahmad M, Swami BL, Ikram S (2016) Plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: a green expertise. J Adv Res 7:17–28CrossRefPubMedGoogle Scholar
  2. Åkerman ME, Chan WCW, Laakkonen P (2002) Nanocrystal targeting in vivo. PNAS 99:12617–12621CrossRefPubMedGoogle Scholar
  3. Ankana S, Prasad TNVKV, Elumalai EK, Savithramma N (2010) Production of biogenic silver nanoparticles using Boswellia ovalifoliolata stem bark. Dig J Nanometer Biostruct 5:369–372Google Scholar
  4. Baker C, Pradhan A, Pakstis L, Pochan DJ, Shah SI (2005) Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol 5:244–249CrossRefPubMedGoogle Scholar
  5. Balouiri M, Sadiki M, Ibnsouda SK (2016) Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal 1:1–9Google Scholar
  6. Baran ET, Ozer N, Hasirci V (2002) In vitro half-life of nanoencapsulated L-asparaginase. J Mat Sci Mat in Med 13:1113–1121Google Scholar
  7. Bazile D, Prud’Homme C, Bassoullet MT (1995) Stealth PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 84:493–498CrossRefPubMedGoogle Scholar
  8. Bhattacharya R, Mukherjee P (2008) Biological properties of “naked” metal nanoparticles. Adv Drug Del Rev 60:1289–1306CrossRefGoogle Scholar
  9. Borm PJ (2002) Particle toxicology: from coal mining to nanotechnology. Inhal Toxicol 14:311–324CrossRefPubMedGoogle Scholar
  10. Borm PJ, Kreyling W (2004) Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. J Nanosci Nanotechnol 4:521–531CrossRefPubMedGoogle Scholar
  11. Bowman MC, Ballard TE, Ackerson CJ, Feldheim DJ, Margolis DM, Melander C (2008) Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc 130:6896–6897CrossRefPubMedPubMedCentralGoogle Scholar
  12. Cascone MG, Lazzeri L, Carmignani C (2002) Gelatin nanoparticles produced by a simple W/O emulsion as drug delivery system for methotrexate. J Mat Sci Mat in Med 13:523–526CrossRefGoogle Scholar
  13. Chang JS, Chang KLB, Hwang DF (2007) In vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ Sci Technol 41:2064–2068CrossRefPubMedGoogle Scholar
  14. Chawengkijwanich C, Hayata Y (2008) Development of TiO2 powder-coated food packaging film and its ability to inactivate Escherichia coli in vitro and in actual tests. Int J Food Microbiol 123:288–292CrossRefPubMedGoogle Scholar
  15. Choi AO, Cho SJ, Desbarats J (2007) Quantum dot-induced cell death involves fats up regulation and lipid peroxidation in human neuroblastoma cells. J Nanobiotech 12:1CrossRefGoogle Scholar
  16. Chorianopoulos NG, Tsoukleris DS, Panagou EZ, Falaras P, Nychas GJE (2011) Use of titanium dioxide (TiO2) photocatalysts as alternative means for Listeria monocytogenes biofilm disinfection in food processing. Food Microbiol 28:164–170CrossRefPubMedGoogle Scholar
  17. Cioffi N, Torsi L, Ditaranto N, Tantillo G, Ghibelli L, Sabbatini L (2005) Copper nanoparticle/polymer composites with antifungal and bacteriostatic properties. Chem Mater 17:5255–5262CrossRefGoogle Scholar
  18. CLSI, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved Standard, 9th ed., CLSI document M07-A9. Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA, 2012Google Scholar
  19. Cornor EE, Mwamuka J, Gole A (2005) Gold nanoparticles are taken by human cells but do not cause acute toxicity. Small 1:325–327CrossRefGoogle Scholar
  20. Costigan S (2006) The toxicology of nanoparticles used in health care products. Available at the website of the medicines and healthcare products regulatory agency, Department of Health, UK. Accessed 20 November 2006. http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&nodeId=996
  21. De Jong WH, Geertsma RE, Roszek B (2005) Nanotechnology in medical applications. Possible risks for human health. Report 265001002/2005, National Institute of Public Health and Environment (RIVM), Bilthoven, The NetherlandsGoogle Scholar
  22. Dibrov P, Dzioba J, Gosink KK, Hase CC (2012) Chemiosmotic mechanism of antimicrobial activity of Ag(+) in Vibrio cholerae. Antimicrob Agents Chemother 46:2668–2670CrossRefGoogle Scholar
  23. Donaldson K, Stone V (2003) Current hypotheses on the mechanism of toxicity of ultrafine particles. Ann 1st Super Sanita 39:405–410Google Scholar
  24. Donaldson K, Stone V, Clouter A (2001) Ultrafine Particles. Occup Env Med 58:211–216CrossRefGoogle Scholar
  25. Donaldson K, Tran L, Jimenez LA (2005) Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2:10CrossRefPubMedPubMedCentralGoogle Scholar
  26. Dreher KL (2004) Toxicological highlight. Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles. Toxicol Sci 77:3–5CrossRefPubMedGoogle Scholar
  27. Duffy EF, Touati FA, Kehoe SC, McLoughlin OA, Gill LW, Gernjak W, Oller I, Maldonado MI, Malato S, Cassidy J, Reed RH, McGuigan KG (2002) A novel TiO2-assisted solar photocatalytic batch-process disinfection reactor for the treatment of biological and chemical contaminants in domestic drinking water in developing countries. Sol Energy 77:649–655CrossRefGoogle Scholar
  28. Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Disc 2:347–360CrossRefGoogle Scholar
  29. Fang C, Shi B, Pei YY (2006) In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 27:27–36CrossRefPubMedGoogle Scholar
  30. Ferrari M (2005) Cancer nanotechnology: opportunity and challenges. Nat Rev Cancer 5:161–171CrossRefPubMedGoogle Scholar
  31. Feynman R (1959) There’s plenty of room at the bottom. A talk given at the annual meeting of the American Physical Society at the California Institute of Technology, December 29, 1959. A full transcript of the lecture can be found at www.zyvex.com/nanotech/feynman.html
  32. Fishbein I, Chorny M, Banai S (2001) Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model. Arterioscler Thromb Vasc Biol 21(9):1434CrossRefPubMedGoogle Scholar
  33. Flores ME, Negrete J, Torres VG (2003) Structure and properties of Zn-Al-Cu alloy reinforced with alumina particles. Mater Des 24:281–286Google Scholar
  34. Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM (2004) Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother 54(6):1019–1024CrossRefPubMedGoogle Scholar
  35. Giancivincenzo PD, Marradi M, Martinez-Avila OM, Bedoya LM, Alcami J, Penades S (2010) Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents. Bioorg Med Chem Lett 20:2718–2721CrossRefGoogle Scholar
  36. Granum B, Lovik M (2002) The effect of nanoparticles on immune allergic responses. Toxicol Sci 65:7–17CrossRefPubMedGoogle Scholar
  37. Gurunathan S (2009) Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloids Surf B Biointerfaces 74:328–335CrossRefPubMedGoogle Scholar
  38. Hardman R (2006) A toxicological review of quantum dots: toxicity depends on physiochemical and environmental factors. Environ Healh Perspect 114:165–172CrossRefGoogle Scholar
  39. Higby GJ (1990) Gold in medicine: a review of its use in the west before 1900. Gold Bull 15:130–140CrossRefGoogle Scholar
  40. Hirsch LR, Stafford RJ, Bankson JA (2003) Nanoshell-mediated near infrared thermal therapy of tumors under magnetic resonance guidance. Proc Nat Acad Sci USA 100:13549–13554CrossRefPubMedGoogle Scholar
  41. Hood JR, Wilkinson JM, Cavanagh HMA (2003) Evaluation of common antibacterial screening methods utilized in essential oils research. J Essent Oil Res 15(6):428–433CrossRefGoogle Scholar
  42. Hoshino A, Fujioka K, Oku T (2004) Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 4:2163–2169CrossRefGoogle Scholar
  43. Hu C, Lan Y, Qu J, Hu X, Wang A (2006) Ag/AgBr/TiO2 visible light photocatalyst for destruction of azodyes and bacteria. J Phys Chem B 110:4066–4072CrossRefPubMedGoogle Scholar
  44. Huang L (2005) Controllable preparation of Nano-MgO and investigation of its bactericidal properties. J Inorg Biochem 99:986–993CrossRefPubMedGoogle Scholar
  45. Kalishwaralal K, Banumathi E, Pandian SBRK, Deepak V, Muniyandi J, Eom SH (2009) Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf B Biointerf 73:51–57CrossRefGoogle Scholar
  46. Kawano T, Yamagata M, Takahishi H (2006) Stabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulses. J Cont Rel 111:382–389CrossRefGoogle Scholar
  47. Kipp JE (2004) The role of solid nanoparticle technology in the parental delivery of poorly-water-soluble-drugs. Int J Pharm 284:109–122CrossRefPubMedGoogle Scholar
  48. Koper O, Klabunde J, Marchin G, Klabunde KJ, Stoimenov P, Bohra L (2002) Nanoscale powders and formulations with biocidal activity toward spores and vegetative cells of Bacillus species, viruses, and toxins. Curr Microbiol 44:49–55CrossRefPubMedGoogle Scholar
  49. Kreyling WG, Semmler M, Moller W (2004) Dosimetry and toxicology of ultrafine particles. J Aerosol Med 17:140–152CrossRefPubMedGoogle Scholar
  50. Kwak K, Kim C (2005) Viscosity and thermal conductivity of copper oxide nanofluid dispersed in ethylene glycol. Korea Aust Rheol J 17:35–40Google Scholar
  51. Lai MK, Chang CY, Lian YW (2006) Application of gold nanoparticles to microencapsulation of thioridazine. J Cont Rel 111:352–361CrossRefGoogle Scholar
  52. Lara HH, Ayala-Nunez NV, Turrent LI, Padilla CR (2010) Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotech 8:1–9CrossRefGoogle Scholar
  53. Lavan DA, McGuire T, Langer R (2003) Small scale systems for in vivo drug delivery. Nat Biotechnol 21:1184–1191CrossRefPubMedGoogle Scholar
  54. Li B, Logan BE (2004) Bacterial adhesion to glass and metal oxide surfaces. Coll Surf B 36:81–90CrossRefGoogle Scholar
  55. Lin W, Huang YW, Zhou XD (2006) In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharma 217:252–259CrossRefGoogle Scholar
  56. Liu Y, Li J, Qiu XF, Burda C (2007) Bactericidal activity of nitrogen-doped metal oxide nanocatalysts and the influence of bacterial extracellular polymeric substances (EPS). J Photochem Photobiol A Chem 190:94–100CrossRefGoogle Scholar
  57. Loo C, Lin A, Hirsch L (2004) Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat 3:33–40CrossRefPubMedGoogle Scholar
  58. Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk JM, Lau GK, Che CM (2008) Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther 13:253–262PubMedPubMedCentralGoogle Scholar
  59. Makarov VV, Love AJ, Sinitsyna OV, Makarova SS, Yaminsky IV, Taliansky ME, Kalinina NO (2014) Green nanotechnologies: synthesis of nanoparticles using plants. Acta Natur 6(1):35–44Google Scholar
  60. Min JS, Kim KS, Kim SW, Jung JH, Lamsal K, Kim SB, Jung M, Lee YS (2009) Effects of colloidal silver nanoparticles on Sclerotium forming Phytopathogenic fungi. Plant Pathol J 25(4):376–380CrossRefGoogle Scholar
  61. Moghimi SM, Hunter JC, Murray JC (2001) Long circulating and target specific nanoparticles: theory and practice. Pharmacol Rev 53:283–318PubMedPubMedCentralGoogle Scholar
  62. Monteiro-Riviere NA, Nemanich RJ, Inman AO (2005) Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 155:377–384CrossRefPubMedGoogle Scholar
  63. Niidome T, Yamagata M, Okamoto Y (2006) PEG-modified gold nanorods with a stealth character for in vivo applications. J Cont Rel 114:343–347CrossRefGoogle Scholar
  64. Nobs L, Buccheger F, Gurny R (2004) Poly (lactic acid) nanoparticles labeled with biologically active Neutravidin™ for active targeting. Eur J Pharm Biopharm 58:483–490CrossRefPubMedGoogle Scholar
  65. Oberdörster G, Maynard A, Donaldson K (2005) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:1–8CrossRefGoogle Scholar
  66. Obordoster G (1996) Significance of particle parameters in the evaluation of exposure dose response relationships of inhaled particles. Inhal Toxicol 8:73–89Google Scholar
  67. Peracchia MT, Fattal E, Desmaele D (1999) Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Release 60:121–128CrossRefPubMedGoogle Scholar
  68. Pinto DB, Shukla S, Perkas N, Gedanken A, Sarid R (2009) Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with Mercapto ethane sulfonate. Bioconjug Chem 20:1497–1502CrossRefGoogle Scholar
  69. Rai RV, Bai JA (2011) Nanoparticles and their potential application as antimicrobials. In: Méndez V (ed) Science against microbial pathogens, communicating current research and technological advances. Badajoz Formatex, pp 197–209Google Scholar
  70. RaviKumar MN, Gameti M, Mohapatra SS (2004) Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo. J Nanosci Nanotech 4:876–881CrossRefGoogle Scholar
  71. Ravishankar V, Rai A, Jamuna B (2011) Nanoparticles and their potential application as antimicrobials. Science against microbial pathogens: communicating current research and technological advances FORMATEX 1:197–209Google Scholar
  72. Ren G, Hu D, Cheng EWC, Vargas-Reus MA, Reip P, Allaker RP (2009) Characterisation of copper oxide nanoparticles for antimicrobial applications. Int J Antimicrob Agents 33:587–590CrossRefPubMedGoogle Scholar
  73. Richards R, Li W, Decker S, Davidson C, Koper O, Zaikovski V, Volodin A, Rieker T, Klabunde K (2000) Consolidation of metal oxide nanocrystals. Reactive pellets with controllable pore structure that represent a new family of porous, inorganic materials. J Am Chem Soc 122:4921–4925CrossRefGoogle Scholar
  74. Rupareli JP, Chatterjee AK, Duttagupta SP, Mukherji S (2008) Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater 4:707–771CrossRefGoogle Scholar
  75. Sadiq M, Chowdhury B, Chandrasekaran N, Mukherjee A (2009) Antimicrobial sensitivity of Escherichia coli to alumina nanoparticles. Nanomed Nanotech Biol Med 5:282–286CrossRefGoogle Scholar
  76. Saez A, Guzman M, Molpeceres J (2000) Freeze drying of poly-caprolactone and poly (D-L- lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmokinetics of loaded drugs. Eur J Pharm Bipharm 50:379–387CrossRefGoogle Scholar
  77. Sahayaraj K, Rajesh S (2011) Bionanoparticles: synthesis and antimicrobial applications, science against microbial pathogens: communicating current research and technological advances. In: Me’ndez-Vilas A (ed) FORMATEX, pp 228–244Google Scholar
  78. Sarkar S, Jana AD, Samanta SK, Mostafa G (2007) Facile synthesis of silver nanoparticles with highly efficient anti-microbial property. Polyhedron 26:4419–4426CrossRefGoogle Scholar
  79. Sayes CM, Liang F, Hudson JL (2006) Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 161:135–142CrossRefPubMedGoogle Scholar
  80. Scenihr (2006) EU Scientific Comittee on emerging and newly identified health risks. Modified opinion on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. SCENIHR/002/05Google Scholar
  81. Seki J, Sonoke S, Saheki A (2004) A nanometer lipid emulsion, lipid nano-sphere(LNS) as a parental drug carrier for passive drug targeting. Int J Pharm 273:75–83CrossRefPubMedGoogle Scholar
  82. Senior J, Gregoriadis G (1982) Is half-life of circulating small unilamellar liposomes determined by changes in their permeability? FEBS Lett 145:109–114CrossRefPubMedGoogle Scholar
  83. Senior J, Crawley JCW, Fisher D (1985) Influence of surface hydrophobicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1062:77–82CrossRefGoogle Scholar
  84. Sharma VK, Yngard RA, Lin Y (2009) Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interf Sci 145:83–96CrossRefGoogle Scholar
  85. Shaw IC (1999) Gold-based therapeutic agents. Chem Rev 99:2589–2600CrossRefGoogle Scholar
  86. Sheikpranbabu S, Kalishwaralal K, Venkataraman D, Eom SH, Park J, Gurunathan S (2009) Silver nanoparticles inhibit VEGF-and IL-1b-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells. J Nanobiotechnol 7:1–8CrossRefGoogle Scholar
  87. Shim J, Kang SH, Park WS (2004) Transdermal delivery of minoxidil with block copolymer nanoparticles. J Cont Rel 97:477–484CrossRefGoogle Scholar
  88. Simpson CA, Huffman BJ, Gerdon AE, Cliffel DE (2010) Unexpected toxicity of monolayer protected gold clusters eliminated by PEG-thiol place exchange reactions. Chem Res Toxicol 23:1608–1616CrossRefPubMedPubMedCentralGoogle Scholar
  89. Soumya RS, Hela PG (2013) Nano silver based targeted drug delivery for treatment of cancer. Pharm Lett 5(4):189–197Google Scholar
  90. Stern JM, Stanfield J, Lotan Y (2007) Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. J Endourol 21:939–943CrossRefPubMedGoogle Scholar
  91. Stoimenov PK (2002) Metal oxide nanoparticles as bactericidal agents. Langmuir 18:6679–6686CrossRefGoogle Scholar
  92. Sun RW, Rong C, Chung NPY, Ho CM, Lin CLS, Che CM (2005) Silver nanoparticles fabricated in Hepes buffer exhibit a cryoprotective activities toward HIV-1 infected cells. Chem Commun:5059–5061Google Scholar
  93. Sunada K, Kikuchi Y, Hashimoto K, Fujishima A (1998) Bactericidal and detoxification effects of TiO2 thin film photocatalysts. Env Sci Tech 32:726–728CrossRefGoogle Scholar
  94. Svenson S, Tomalia DA (2005) Dendrimers in biomedical applications-reflections on the field. Adv Dru Del Rev 57:2106–2129CrossRefGoogle Scholar
  95. Taniguchi N (1974) On the basic concept of ‘nano-technology’ proc Intl Conf prod Eng Tokyo. Part II, Japan Society of Precision Engineering 5–10:10Google Scholar
  96. The Royal Society and The Royal Academy of Engineering (2004) Nanoscience and nanotechnologies: opportunities and uncertainties. London, UK. Accessed 10 Aug 2004. http://www.nanotec.org.uk/finalReport.htm
  97. Wei C, Lin WY, Zainal Z, Williams NE, Zhu K, Kruzic AP, Smith RL, Rajeshwar K (2004) Bactericidal activity of TiO2 photocatalyst in aqueous media: toward a solar-assisted water disinfection system. Environ Sci Technol 28:934–938CrossRefGoogle Scholar
  98. Wist J, Sanabria J, Dierolf C, Torres W, Pulgarin C (2004) Evaluation of photocatalytic disinfection of crude water for drinking water production. J Photochem Photobiol A Chem 147:241–246CrossRefGoogle Scholar
  99. Xia T, Kovochich M, Brant J (2006) Comparison of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794–1807CrossRefPubMedGoogle Scholar
  100. Xu JF, Ji W, Shen ZX, Tang SH, Ye XR, Jia DZ, Xin XQ (2009) Preparation and characterization of CuO nanocrystals. J Solid State Chem 147:516–519CrossRefGoogle Scholar
  101. Yamakoshi Y, Umezawa N, Ryu A (2003) Active oxygen species generated from photo-excited fullerene (C-60) as potential medicines: O2−versus 1 O2. J Am Chem Soc 125:12803–12809CrossRefPubMedGoogle Scholar
  102. Yu H, Chen M, Rice PM, Wang SX, White RL, Sun X (2005) Dumbbell like bio-functional Au-Fe 3O4 nanoparticles. Nano Lett 5(2):379–382CrossRefPubMedGoogle Scholar
  103. Zhang L, Yu Y, Xiang X (2004) Camptothecin derivative loaded poly(caprolactone co lactide)-b-PEG-b-poly-(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Cont Rel 95:135–148CrossRefGoogle Scholar
  104. Zhang LL, Jiang YH, Ding YL, Povey M, York D (2007) Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (znonanofluids). J Nanopart Res 9:479–489CrossRefGoogle Scholar
  105. Zharov VP (2006) Photothermalnanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys J 90:619–627CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Zunera Iqbal
    • 1
  • Sumera Iqbal
    • 1
  1. 1.Department of BotanyLahore College for Women UniversityLahorePakistan

Personalised recommendations